DELTA HEALTH
*News Alert* DELTA HEALTH spotlights its premier, directly managed, multi-specialty, US FDA Phase 2 and pivotal Phase 3 clinical trial investigative sites in Asia
SPEARHEADING MEDICAL INNOVATIONS
The DELTA HEALTH GROUP is an international healthcare conglomerate with a comprehensive portfolio spanning four core strategic areas: innovative medical R&D, global network of dedicated, premier clinical trial investigative sites, international telemedicine services and an advanced medical solutions division
Overview
Mission & Vision
Initially starting with the operation of a group of successful clinical trial investigative sites in the United States at the time of embarking on its journey more than two decades back, the DELTA HEALTH GROUP has progressively evolved and diversified its capabilities in clinical drug development and international healthcare.
With a passion for connecting medical innovations to the world of patients, diseases and treatments, we assist partners in the healthcare sector optimize and develop new drugs, biologics and medical devices that aim to offer advanced therapies and an improvement to available patient care.
INTERNATIONAL TELEMEDICINE
Overcoming the barriers of distance and resource limitations, our international teams of distinguished physicians and surgeons continue to deliver personalized specialist care for patients from assigned geographic regions around the world.
Medical Innovation
Our "A-Team"
Backed by a time-tested, proven track record spanning over 20+ years, the highly talented and experienced best-in-class specialty providers of the DELTA HEALTH "A-Team" have been pioneering medical innovations and have led full clinical development programs that have resulted in successful regulatory approval of a number of prescription drug products from the United States Food and Drug Administration (FDA) and Health Canada.
These drugs are being used to treat patients in the United States, Canada and a number of other countries around the world.
The DELTA HEALTH "A Team" takes a pragmatic approach with direct supervision of clinical trials throughout the full duration of the projects. This comprehensive strategy plays a pivotal role in the success of ongoing clinical development programs and differentiates us significantly from leading global competitors.
Expertise In
Late Stage Clinical Development
What Differentiates Us From Others
Over two decades of in-person, face-to-face interactions and successful working collaboration with various Therapeutic Area Divisions of the United States FDA for clinical phase programs related to drugs, biologics and medical devices has significantly enhanced our expertise in the area of late stage clinical development.
This direct engagement with the US FDA has spotlighted us as one of the privileged few in the healthcare industry and provided us an edge over others, with more depth and better understanding for successfully directing FDA clinical development programs for partner companies.
Clinical Trial Investigative Sites
"Running clinical trials where patient populations are located"
DELTA HEALTH operates a global network of dedicated and strategically located Clinical Trial Investigative Sites. These premier, multi-speciality investigative sites with extensive experience in conducting new drug development Phase 2 and pivotal Phase 3 clinical trials are managed by the DELTA HEALTH team of highly skilled specialists who have been vetted over time by various therapeutic area Divisions of the United States FDA.
Our Unrelenting Commitment To Excellence
Together with our patient-centric approach and an unrelenting commitment to excellence, our expertise in developing and running end-to-end US FDA new drug development programs and managing global clinical trial sites is grounded in deep knowledge and hands-on experience acquired from working directly with the FDA and successfully directing numerous Phase 1 through pivotal Phase 3 studies across more than 1,000 clinical programs for drugs, biologics, and medical devices.
Our extensive experience with the US FDA gives us the ability to recognize what is required for individual clinical development programs to be successful. One of the main areas of this visibility is in the management of studies conducted under the direct supervision of the DELTA HEALTH team at our selected clinical trial investigative sites.
With an acquired acumen for the US FDA clinical drug development process, the DELTA HEALTH team is a reliable partner to co-develop investigational medical products and advance them in the development cycle through final regulatory approval.
Cross-Functional Global Teams
-
The DELTA HEALTH global teams include dedicated clinical drug development professionals, clinical trial physician investigators, CT site specialists and drug safety experts
-
The clinical development and clinical trial site teams have deep knowledge of legislation and broad based experience of the healthcare industry giving them the flexibility to work in major regions around the world. Learn More Medical R&D - Global Clinical Trial Investigative Sites
-
The DELTA HEALTH International Telemedicine Division includes U.S. Board Certified Medical and Surgical Specialists, U.K. General Medical Council Specialists and other therapeutic area physicians. Learn More International Telemedicine
-
Our Advisory Board includes prestigious names in the world of medicine, including physicians on the faculty of major hospitals and university medical centers in the United States, Canada and the United Kingdom
-
To complement our international medical teams, DELTA HEALTH is supported by experts from our Advanced Medical Solutions Division